Clinical and Experimental Reproductive Medicine

  • 제35권4호
  • /
  • Pages.239-245
  • /
  • 2008
  • /
  • 2233-8233(pISSN)
  • /
  • 2233-8241(eISSN)
대한생식의학회 (The Korean Society for Reproductive Medicine)
권호 표지

조기난소부전의 유전학적 이해

Genetics of Non-Syndromic Premature Ovarian Failure

  • 최영석 (포천중문의과대학교 차병원 여성의학연구소)
  • Choi, Young-Sok (Fertility Center of CHA General Hospital, Pochon CHA University College of Medicine)
  • 발행 : 2008.12.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

키워드

참고문헌

  1. Habbema JD, Collins J, Leridon H, Evers JL, Lunenfeld B. te Velde ER. Towards less confusing terminology in reproductive medicine: a proposal. Hum Reprod 2004; 19: 1497-501 https://doi.org/10.1093/humrep/deh303
  2. Smith S, Pfeifer SM, Collins JA. Diagnosis and management of female infertility. JAMA 2003; 290: 1767-70 https://doi.org/10.1001/jama.290.13.1767
  3. Conway GS. Premature ovarian failure. Br Med Bull 2000; 56: 643-9 https://doi.org/10.1258/0007142001903445
  4. Davison RM, Fox M, Conway GS. Mapping of the POF1 locus and identification of putative genes for premature ovarian failure. Mol Hum Reprod 2000; 6: 314-8 https://doi.org/10.1093/molehr/6.4.314
  5. Lacombe A, Lee H, Zahed L, Choucair M, Muller JM, Nelson SF, et al. Disruption of POF1B binding to nonmuscle actin filaments is associated with premature ovarian failure. Am J Hum Genet 2006; 79: 113-9 https://doi.org/10.1086/505406
  6. Marozzi A, Manfredini E, Tibiletti MG, Furlan D, Villa N, Vegetti W, et al. Molecular definition of Xq common-deleted region in patients affected by premature ovarian failure. Hum Genet 2000; 107: 304-11 https://doi.org/10.1007/s004390000364
  7. Powell CM, Taggart RT, Drumheller TC, Wangsa D, Qian C, Nelson LM, et al. Molecular and cytogenetic studies of an X;autosome translocation in a patient with premature ovarian failure and review of the literature. Am J Med Genet 1994; 52: 19-26 https://doi.org/10.1002/ajmg.1320520105
  8. Tharapel AT, Anderson KP, Simpson JL, Martens PR, Wilroy RS Jr, Llerena JC Jr, et al., Deletion (X)(q26.1-->q28) in a proband and her mother: molecular characterization and phenotypic-karyotypic deductions. Am J Hum Genet 1993; 52: 463-71
  9. Elsheikh M, Dunger DB, Conway GS, Wass JA. Turner's syndrome in adulthood. Endocr Rev 2002; 23: 120-40 https://doi.org/10.1210/er.23.1.120
  10. Zinn AR, Ross JL. Turner syndrome and haploinsufficiency. Curr Opin Genet Dev 1998; 8: 322-7 https://doi.org/10.1016/S0959-437X(98)80089-0
  11. Allingham-Hawkins DJ, Babul-Hirji R, Chitayat D, Holden JJ, Yang KT, Lee C, et al. Fragile X premutation is a significant risk factor for premature ovarian failure: the International Collaborative POF in Fragile X study--preliminary data. Am J Med Genet 1998; 83: 322-5 https://doi.org/10.1002/(SICI)1096-8628(19990402)83:4<322::AID-AJMG17>3.0.CO;2-B
  12. Murray A, Webb J, Dennis N, Conway G, Morton N. Microdeletions in FMR2 may be a significant cause of premature ovarian failure. J Med Genet 1999; 36: 767-70 https://doi.org/10.1136/jmg.36.10.767
  13. Murray A, Webb J, Grimley S, Conway G, Jacobs P. Studies of FRAXA and FRAXE in women with premature ovarian failure. J Med Genet 1998; 35: 637-40 https://doi.org/10.1136/jmg.35.8.637
  14. Dixit H, Rao LK, Padmalatha VV, Kanakavalli M, Deenadayal M, Gupta N, et al. Missense mutations in the BMP15 gene are associated with ovarian failure. Hum Genet 2006; 119: 408-15 https://doi.org/10.1007/s00439-006-0150-0
  15. Laissue P, Christin-Maitre S, Touraine P, Kuttenn F, Ritvos O, Aittomaki K, et al. Mutations and sequence variants in GDF9 and BMP15 in patients with premature ovarian failure. Eur J Endocrinol 2006; 154: 739-44 https://doi.org/10.1530/eje.1.02135
  16. Laissue P, Vinci G, Veitia RA, Fellous M. Recent advances in the study of genes involved in non-syndromic premature ovarian failure. Mol Cell Endocrinol 2008; 282: 101-11 https://doi.org/10.1016/j.mce.2007.11.005
  17. Aittomaki K, Lucena JL, Pakarinen P, Sistonen P, Tapanainen J, Gromoll J, et al. Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell 1995; 82: 959-68 https://doi.org/10.1016/0092-8674(95)90275-9
  18. Crisponi L, Deiana M, Loi A, Chiappe F, Uda M, Amati P, et al. The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis/ ptosis/ epicanthus inversus syndrome. Nat Genet 2001; 27: 159-66 https://doi.org/10.1038/84781
  19. Dixit H, Deendayal M, Singh L. Mutational analysis of the mature peptide region of inhibin genes in Indian women with ovarian failure. Hum Reprod 2004; 19: 1760-4 https://doi.org/10.1093/humrep/deh342
  20. Dixit H, Rao KL, Padmalatha V, Kanakavalli M, Deenadayal M, Gupta N, et al. Expansion of the germline analysis for the INHA gene in Indian women with ovarian failure. Hum Reprod 2006; 21: 1643-4 https://doi.org/10.1093/humrep/del129
  21. Dixit H, Rao LK, Padmalatha V, Kanakavalli M, Deenadayal M, Gupta N, et al. Mutational screening of the coding region of growth differentiation factor 9 gene in Indian women with ovarian failure. Menopause 2005; 12: 749-54 https://doi.org/10.1097/01.gme.0000184424.96437.7a
  22. Guerrero NV, Singh RH, Manatunga A, Berry GT, Steiner RD, Elsas LJ 2nd. Risk factors for premature ovarian failure in females with galactosemia. J Pediatr 2000; 137: 833-41 https://doi.org/10.1067/mpd.2000.109148
  23. Latronico AC, Anasti J, Arnhold IJ, Rapaport R, Mendonca BB, Bloise W, et al. Brief report: testicular and ovarian resistance to luteinizing hormone caused by inactivating mutations of the luteinizing hormone-receptor gene. N Engl J Med 1996; 334: 507-12 https://doi.org/10.1056/NEJM199602223340805
  24. Shelling AN, Burton KA, Chand AL, van Ee CC, France JT, Farquhar CM, et al. Inhibin: a candidate gene for premature ovarian failure. Hum Reprod 2000; 15: 2644-9 https://doi.org/10.1093/humrep/15.12.2644
  25. Liang L, Soyal SM, Dean J. FIGalpha, a germ cell specific transcription factor involved in the coordinate expression of the zona pellucida genes. Development 1997; 124: 4939-47
  26. Soyal SM, Amleh A, Dean J. FIGalpha, a germ cell-specific transcription factor required for ovarian follicle formation. Development 2000; 127: 4645-54
  27. Joshi S, Davies H, Sims LP, Levy SE, Dean J. Ovarian gene expression in the absence of FIGLA, an oocyte-specific transcription factor. BMC Dev Biol 2007; 7: 67 https://doi.org/10.1186/1471-213X-7-67
  28. Rankin TL, O'Brien M, Lee E, Wigglesworth K, Eppig J, Dean J. Defective zonae pellucidae in Zp2-null mice disrupt folliculogenesis, fertility and development. Development 2001; 128: 1119-26
  29. Zhao H, Chen ZJ, Qin Y, Shi Y, Wang S, Choi Y, et al. Transcription factor FIGLA is mutated in patients with premature ovarian failure. Am J Hum Genet 2008; 82: 1342-8 https://doi.org/10.1016/j.ajhg.2008.04.018
  30. Suzumori N, Yan C, Matzuk MM, Rajkovic A. Nobox is a homeobox-encoding gene preferentially expressed in primordial and growing oocytes. Mech Dev 2002; 111: 137-41 https://doi.org/10.1016/S0925-4773(01)00620-7
  31. Rajkovic A, Pangas SA, Ballow D, Suzumori N, Matzuk MM. NOBOX deficiency disrupts early folliculogenesis and oocytespecific gene expression. Science 2004; 305: 1157-9 https://doi.org/10.1126/science.1099755
  32. Choi Y, Qin Y, Berger MF, Ballow DJ, Bulyk ML, Rajkovic A. Microarray analyses of newborn mouse ovaries lacking Nobox. Biol Reprod 2007; 77: 312-9 https://doi.org/10.1095/biolreprod.107.060459
  33. Choi Y, Rajkovic A. Characterization of NOBOX DNA binding specificity and its regulation of Gdf9 and Pou5f1 promoters. J Biol Chem 2006; 281: 35747-56 https://doi.org/10.1074/jbc.M604008200
  34. Elvin JA, Clark AT, Wang P, Wolfman NM, Matzuk MM. Paracrine actions of growth differentiation factor-9 in the mammalian ovary. Mol Endocrinol 1999; 13: 1035-48 https://doi.org/10.1210/me.13.6.1035
  35. Elvin JA, Yan C, Matzuk MM. Growth differentiation factor-9 stimulates progesterone synthesis in granulosa cells via a prostaglandin E2/EP2 receptor pathway. Proc Natl Acad Sci U S A 2000; 97: 10288-93 https://doi.org/10.1073/pnas.180295197
  36. Elvin JA, Yan C, Wang P, Nishimori K, Matzuk MM. Molecular characterization of the follicle defects in the growth differentiation factor 9-deficient ovary. Mol Endocrinol 1999; 13: 1018-34 https://doi.org/10.1210/me.13.6.1018
  37. McGrath SA, Esquela AF, Lee SJ. Oocyte-specific expression of growth/differentiation factor-9. Mol Endocrinol 1995; 9: 131-6 https://doi.org/10.1210/me.9.1.131
  38. Dong J, Albertini DF, Nishimori K, Kumar TR, Lu N, Matzuk MM Growth differentiation factor-9 is required during early ovarian folliculogenesis. Nature 1996; 383: 531-5 https://doi.org/10.1038/383531a0
  39. Qin Y, Choi Y, Zhao H, Simpson JL, Chen ZJ, Rajkovic A. NOBOX homeobox mutation causes premature ovarian failure. Am J Hum Genet 2007; 81: 576-81 https://doi.org/10.1086/519496
  40. Zhao Y, Guo YJ, Tomac AC, Taylor NR, Grinberg A, Lee EJ, et al. Isolated cleft palate in mice with a targeted mutation of the LIM homeobox gene lhx8. Proc Natl Acad Sci U S A 1999; 96: 15002-6 https://doi.org/10.1073/pnas.96.26.15002
  41. Choi Y, Ballow DJ, Xin Y, Rajkovic A. Lim homeobox gene, lhx8, is essential for mouse oocyte differentiation and survival. Biol Reprod 2008; 79: 442-9 https://doi.org/10.1095/biolreprod.108.069393
  42. Reddy P, Liu L, Adhikari D, Jagarlamudi K, Rajareddy S, Shen Y, et al. Oocyte-specific deletion of Pten causes premature activation of the primordial follicle pool. Science 2008; 319: 611-3 https://doi.org/10.1126/science.1152257